AGA
TDOC icon

Accuvest Global Advisors’s Teladoc Health TDOC Stock Holding History

Accuvest Global Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-68
Closed -$13K – 54
2020
Q2 		$13K Buy
+68
New +$11.9K 0.03% 50

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DVF
Discovery Value Fund Singapore $34.7M AUM 58.56% 1-Year Est. Return

Accuvest Global Advisors's TDOC Position: Q3 2020 in Review

Accuvest Global Advisors sold out of Teladoc Health (TDOC) in Q3 2020, closing a stake of 68 shares — an estimated $13K sold.

Accuvest Global Advisors first reported a position in TDOC in Q2 2020 and held it in 1 quarter. The position peaked at $13K in Q2 2020. 743 funds tracked by Wall St. Rank hold TDOC as of Q3 2020.

  • Accuvest Global Advisors reported no remaining Teladoc Health position as of Q3 2020 after selling out during the quarter.
  • Accuvest Global Advisors sold 68 Teladoc Health shares in Q3 2020, an estimated $13K.
  • Accuvest Global Advisors first reported a position in Teladoc Health in Q2 2020 and held it in 1 quarter.
  • Accuvest Global Advisors's Teladoc Health position peaked at $13K in Q2 2020.
  • 743 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2020.

Based on Accuvest Global Advisors's 13F filing for Q3 2020, filed 30 Oct 2020.